A quarter-century ago, genetic modification stood as one of the most contentious political and environmental issues in New Zealand. Debate around the technology produced a high-profile royal ...

From expanded vision to immortal bodies, these screen depictions have all stretched our understanding of what technology ...

A digital fruit fly brain quickly became an AI meme machine. It raises tough questions: could machines become conscious, and ...

New research in the British Journal of Cancer shows that the collagen-binding receptor LAIR1 disables the phagocytic machinery of glioma-associated microglia and macrophages through an SHP2, USP22 and ...

A quarter-century ago, genetic modification stood as one of the most contentious political and environmental issues in New Zealand. Authors Sylvia ...

A biotech startup leads a new effort to edit human embryos therapeutically, hoping technical advances will persuade ...

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

Editas Medicine (EDIT) traded higher on Thursday after Australian authorities cleared a Phase 1/2 trial for the company’s gene-editing therapy EDIT-401, and Wells Fargo upgraded the biotech to ...

Anthropic’s claim its AI agents discovered an unusual pattern in viral DNA similar to what’s seen in the gene-editing tool ...

Phase 1/2 clinical trial of EDIT-401 cleared to initiate dosing in patients who require additional LDL-C lowering Company ...

Scientists calculated the massive human and animal sample loss caused by poorly characterized research antibodies and ...

Pathologically, it is characterized by the degeneration of not only primarily dopaminergic but also other types of neurons ...